Nebraska hemp industry faces uncertain future
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHCIndustrySafetyCBDDosing Why This Matters Clinicians need to understand that regulatory uncertainty in…
Medical Cannabis and Anxiety in 2026: What Patients Need to Know Before Treatment
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. AnxietyMental HealthResearchSafetyCBDTHCDosing Why This Matters Clinicians need current evidence on cannabis efficacy and…
Cannabinoid-Based Therapies Linked to Reduced Agitation in Alzheimer’s Patients, Meta …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingMental HealthCBDTHCSafety Why This Matters Clinicians treating Alzheimer’s disease patients…
This Week in Cannabis: Focus on Use Disorder Stigma and Research Barriers
This week’s roundup highlights cannabis use disorder stigma and research limitations at Michigan universities. The focus includes emerging science on cognition and policy shifts. Cannabis use disorder stigma remains a key topic in ongoing cannabis…
In the Mix: 20 More Cannabis Industry Articles — June 19, 2026
This post reviews mixed cannabis industry articles June 19 2026, highlighting clinical relevance and regulatory impacts. It covers key developments in cannabis market trends and clinical updates. Stay informed on evolving cannabis industry insights for…
Michigan universities can’t study dispensary pot on campus. MSU went mobile
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPolicySafetyMental HealthNeurologyAnxietyIndustry Why This Matters Michigan’s restriction on campus…
Cannabinoid-Based Therapies Linked to Reduced Agitation in Alzheimer’s Patients, Meta …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingMental HealthCBDTHCSafety Why This Matters Clinicians treating Alzheimer’s disease patients…
Medicinal Cannabis Matters: Friday Roundup – 19 June 2026
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainAnxietyMental HealthResearchPolicySafetyDosing Dr. Caplan’s Take I appreciate patient narratives, but a single…
CBD and Cardiovascular Recovery: HRV, Blood Pressure – Dr. Damas Cannabis
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDResearchSafetyAnxietyAgingDosingPolicy Why This Matters Clinicians should be cautious about recommending CBD for…
Anandamide – Chemical of Blissfulness
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyMental HealthCBDTHCAnxietySleep Clinical Summary I cannot generate a meaningful clinical summary from…